Medical Developments International Limited
MDDVF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $39 | $33 | $32 | $22 |
| % Growth | 17.8% | 2.5% | 47.4% | – |
| Cost of Goods Sold | $10 | $9 | $35 | $25 |
| Gross Profit | $29 | $24 | -$3 | -$3 |
| % Margin | 75.3% | 73.5% | -7.8% | -13.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $22 | $33 | $33 | $22 |
| SG&A Expenses | $26 | $35 | $36 | $25 |
| Sales & Mktg Exp. | $4 | $3 | $4 | $3 |
| Other Operating Expenses | $0 | -$0 | -$19 | -$12 |
| Operating Expenses | $26 | $35 | $18 | $13 |
| Operating Income | $3 | -$11 | -$14 | -$16 |
| % Margin | 7.9% | -33.3% | -44.6% | -71.5% |
| Other Income/Exp. Net | -$3 | -$22 | $0 | -$0 |
| Pre-Tax Income | $0 | -$33 | -$7 | -$16 |
| Tax Expense | $0 | $8 | -$2 | -$4 |
| Net Income | $0 | -$41 | -$6 | -$12 |
| % Margin | 0.2% | -123.7% | -17.3% | -56.5% |
| EPS | 0.001 | -0.47 | -0.067 | -0.17 |
| % Growth | 100.2% | -605.7% | 60.8% | – |
| EPS Diluted | 0.001 | -0.47 | -0.067 | -0.17 |
| Weighted Avg Shares Out | 118 | 86 | 84 | 72 |
| Weighted Avg Shares Out Dil | 112 | 86 | 84 | 72 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $3 | $3 | $3 |
| EBITDA | $2 | -$29 | -$4 | -$13 |
| % Margin | 4.3% | -88.8% | -13.2% | -58.6% |